Researchers Identify Fifth Gene Responsible for Joubert Syndrome
An international study by researchers at Seattle Children’s Hospital Research Institute, the University of Washington School of Medicine, and Radboud University in Nijmegen, Netherlands has identified a new genetic cause for Joubert syndrome (JS).
An international study by researchers at Seattle Children’s Hospital Research Institute, the University of Washington School of Medicine, and Radboud University in Nijmegen, Netherlands has identified a new genetic cause for Joubert syndrome (JS). Joubert syndrome is an inherited condition that affects development of the cerebellum and brainstem, the structures in the brain that coordinate movements and regulate basic functions such as breathing, swallowing, heart rate and consciousness. The study, published in the June 10, 2007 issue of Nature Genetics, confirms key information about the genetic changes that cause JS and cellular structures called cilia, conclusively placing JS in a class of recently identified ciliopathic conditions. Though the disease is statistically rare and four other genetic markers have been previously identified, researchers believe these findings are important.
Joubert syndrome can result in developmental delay, poor physical coordination, irregular breathing, visual impairment, kidney failure and extra digits. Diverse symptoms may occur making diagnosis difficult, though patients typically feature a characteristic configuration of the brainstem and cerebellum on magnetic resonance imaging (MRI), where the abnormally developed brain stem resembles the shape of a molar tooth. The researchers’ discovery of mutation in the gene (RPGRIP1L) now paves the way for definitive DNA testing that can more conclusively diagnose JS in some patients, and also identify asymptomatic carriers who might unknowingly pass the condition to their future children.
In addition to identifying a fifth gene for JS, the study also sheds light on the role of cilia in this disease and possibly others. Primary cilia are tiny projections on cell surfaces that allow the inside of cells to communicate with their outside environment. Recent research has found that defects in cilia function lead to various newly identified syndromes called ciliopathies. The paper describes a genetic change that prevents interaction between two particular cilia proteins, presumably disrupting cilia function and causing JS. This links JS to other diseases such as Leber congenital amaurosis, Senior-Loken syndrome and nephronophthisis, the most common genetic cause of kidney failure in children. All these conditions share disruptions in the protein networks of cilia. Further, this study exemplifies the power of international collaborative research, an increasingly important trend in biomedical discoveries.
Study findings add substantially to the way JS and other ciliopathies will be identified and understood. “By discovering this gene, we’re on the forefront of research changing how we think about brain, retina and kidney development,” said Dr. Dan Doherty, co-author on the study, from the Division of Genetics and Developmental Medicine at Seattle Children’s Hospital Research Institute. “These advances will lead to better understanding of both normal and abnormal brain development and eventually improved treatments for a variety of diseases.”
Ongoing genetic research at Seattle Children’s Hospital Research Institute will look for additional mutations responsible for Joubert syndrome, and continue to study how genes work together to build and maintain the brain, retina and kidney. Other Children’s researchers on the team included Drs. Melissa A. Parisi, Ian A. Glass and Phillip Chance, and Nicholas T. Gorden. They were joined by Dr. Federico M. Farin from the University of Washington School of Medicine and international researchers from the Netherlands, Germany and Turkey.
For a complete copy of the study, please visit: http://www.nature.com/ng/journal/v39/n7/full/ng2069.html.
For more information on Joubert syndrome, please visit: http://depts.washington.edu/joubert/ and http://www.joubertsyndrome.org.
About Seattle Children’s
Seattle Children’s Hospital, Foundation and Research Institute together deliver superior patient care, advance new discoveries and treatments through pediatric research, and raise funds to create better futures for patients. Consistently ranked as one of the top 10 children’s hospitals in the country by U.S. News & World Report, Seattle Children’s Hospital specializes in meeting the unique physical, emotional and developmental needs of children from infancy through young adulthood. Through the collaboration of physicians in nearly 60 pediatric subspecialties, Seattle Children’s Hospital provides inpatient, outpatient, diagnostic, surgical, rehabilitative, behavioral, and emergency and outreach services to families from around the world.
Located in downtown Seattle’s biotech corridor, Seattle Children’s Research Institute is pushing the boundaries of medical research to find cures for pediatric diseases and improve outcomes for children all over the world. Internationally recognized investigators and staff at the research institute are advancing new discoveries in cancer, genetics, immunology, pathology, infectious disease, injury prevention, bioethics and much more.
Seattle Children’s Hospital and Research Foundation and Seattle Children’s Hospital Guild Association work together to gather community support and raise funds for uncompensated care, clinical care and research. The foundation receives nearly 80,000 gifts each year, from lemonade stand proceeds to corporate sponsorships. Seattle Children’s Hospital Guild Association is the largest all-volunteer fundraising network for any hospital in the country, serving as the umbrella organization for 450 groups of people who turn an activity they love into a fundraiser. Support from the foundation and guild association makes it possible for Seattle Children’s care and research teams to improve the health and well-being of all kids.
For more information, visit seattlechildrens.org or follow us on Twitter, Facebook and Instagram.